You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-CXCR4 (phospho S339) antibody (ab74012)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-CXCR4 (phospho S339) antibody
See all CXCR4 products (19) ...

Description

Rabbit polyclonal to CXCR4 (phospho S339)

Specificity

ab74012 detects endogenous levels of CXCR4 only when phosphorylated at serine 339 (Mouse: Ser 346).

Tested applications

WB, ELISA, IHC-P, ICC/IFmore details

Cross reactivity

Reacts with

Mouse, Human

Immunogen

Synthetic phosphopeptide derived from human CXCR4 around the phosphorylation site of serine 339 (H-S-SP-V-S).

Positive control

Human brain carcinoma tissue. Extracts from HUVEC cells treated with etoposide (25uM, 24hours). HeLa cells.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: 50% Glycerol, PBS (without Mg2+ and Ca2+), 150mM Sodium chloride, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Purification notes

ab74012 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.

Clonality

Polyclonal

Isotype

IgG

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - CXCR4 (phospho S339) antibody (ab74012)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - CXCR4 (phospho S339) antibody (ab74012) image (enlarge)

  • Western blot - CXCR4 (phospho S339) antibody (ab74012)Western blot - CXCR4 (phospho S339) antibody (ab74012) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - CXCR4 (phospho S339) antibody (ab74012)Immunocytochemistry/ Immunofluorescence - CXCR4 (phospho S339) antibody (ab74012) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab74012 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

ELISA: 1/20000.
ICC/IF: 1/500 - 1/1000.
IHC-P: 1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer before commencing with IHC staining protocol (may require optimization).
WB: 1/500 - 1/1000. Detects a band of approximately 45 kDa (predicted molecular weight: 40 kDa).


Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Receptor for the C-X-C chemokine CXCL12/SDF-1 that transduces a signal by increasing intracellular calcium ions levels and enhancing MAPK1/MAPK3 activation. Acts as a receptor for extracellular ubiquitin; leading to enhance intracellular calcium ions and reduce cellular cAMP levels. Involved in haematopoiesis and in cardiac ventricular septum formation. Plays also an essential role in vascularization of the gastrointestinal tract, probably by regulating vascular branching and/or remodeling processes in endothelial cells. Could be involved in cerebellar development. In the CNS, could mediate hippocampal-neuron survival. Acts as a coreceptor (CD4 being the primary receptor) for HIV-1 X4 isolates and as a primary receptor for some HIV-2 isolates. Promotes Env-mediated fusion of the virus.

Tissue specificity

Expressed in numerous tissues, such as peripheral blood leukocytes, spleen, thymus, spinal cord, heart, placenta, lung, liver, skeletal muscle, kidney, pancreas, cerebellum, cerebral cortex and medulla (in microglia as well as in astrocytes), brain microvascular, coronary artery and umbilical cord endothelial cells. Isoform 1 is predominant in all tissues tested.

Involvement in disease

Defects in CXCR4 are a cause of WHIM syndrome (WHIM) [MIM:193670]; also known as warts, hypogammaglobulinemia, infections and myelokathexis. WHIM syndrome is an immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis.

Sequence similarities

Belongs to the G-protein coupled receptor 1 family.

Domain

The amino-terminus is critical for ligand binding. Residues in all four extracellular regions contribute to HIV-1 coreceptor activity.

Post-translational
modifications

Phosphorylated on agonist stimulation. Rapidly phosphorylated on serine and threonine residues in the C-terminal. Phosphorylation at Ser-324 and Ser-325 leads to recruitment of ITCH, ubiquitination and protein degradation.
Ubiquitinated by ITCH at the cell membrane on agonist stimulation. The ubiquitin-dependent mechanism, endosomal sorting complex required for transport (ESCRT), then targets CXCR4 for lysosomal degradation. This process is dependent also on prior Ser-/Thr-phosphorylation in the C-terminal of CXCR4. Also binding of ARRB1 to STAM negatively regulates CXCR4 sorting to lysosomes though modulating ubiquitination of SFR5S.
Sulfation on Tyr-21 is required for efficient binding of CXCL12/SDF-1alpha and promotes its dimerization.
O- and N-glycosylated. Asn-11 is the principal site of N-glycosylation. There appears to be very little or no glycosylation on Asn-176. N-glycosylation masks coreceptor function in both X4 and R5 laboratory-adapted and primary HIV-1 strains through inhibiting interaction with their Env glycoproteins. The O-glycosylation chondroitin sulfate attachment does not affect interaction with CXCL12/SDF-1alpha nor its coreceptor activity.

Cellular localization

Cell membrane. In unstimulated cells, diffuse pattern on plasma membrane. On agonist stimulation, colocalizes with ITCH at the plasma membrane where it becomes ubiquitinated.

Target information above from: UniProt accessionP61073 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • FB22 antibody
  • C-X-C chemokine receptor type 4 antibody
  • CD184 antibody
  • CD184 antigen antibody
  • Chemokine (C X C motif) receptor 4 antibody
  • Chemokine CXC Motif Receptor 4 antibody
  • CXC-R4 antibody
  • CXCR-4 antibody
  • CXCR4 antibody
  • CXCR4_HUMAN antibody
  • D2S201E antibody
  • FB22 antibody
  • Fusin antibody
  • HM89 antibody
  • HSY3RR antibody
  • LAP 3 antibody
  • LAP3 antibody
  • LCR1 antibody
  • LESTR antibody
  • Leukocyte derived seven transmembrane domain receptor antibody
  • Leukocyte-derived seven transmembrane domain receptor antibody
  • Lipopolysaccharide associated protein 3 antibody
  • Neuropeptide Y receptor Y3 antibody
  • NPY3R antibody
  • NPYR antibody
  • NPYRL antibody
  • NPYY3 antibody
  • NPYY3R antibody
  • Probable G protein coupled receptor lcr1 homolog antibody
  • SDF 1 receptor antibody
  • SDF-1 receptor antibody
  • Stromal cell derived factor 1 receptor antibody
  • Stromal cell-derived factor 1 receptor antibody
  • WHIM antibody
see all

Anti-CXCR4 (phospho S339) antibody images:

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - CXCR4 (phospho S339) antibody (ab74012)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - CXCR4 (phospho S339) antibody (ab74012)

Immunohistochemistry analysis of paraffin-embedded human brain carcinoma tissue using ab74012, at 1/50 dilution, in the presence (right panel) or absence (left panel) of the immunising phosphopeptide.

  Western blot - CXCR4 (phospho S339) antibody (ab74012)

Western blot - CXCR4 (phospho S339) antibody (ab74012)

All lanes : Anti-CXCR4 (phospho S339) antibody (ab74012) at 1/500 dilution

Lane 1 : Extracts from HUVEC cells treated with etoposide (25uM, 24hours)
Lane 2 : Extracts from HUVEC cells treated with etoposide (25uM, 24hours) with the immunising phosphopeptide at 5 µg

Lysates/proteins at 5 µg per lane.


Predicted band size : 40 kDa
Observed band size : 45 kDa (why is the actual band size different from the predicted?)

  Immunocytochemistry/ Immunofluorescence - CXCR4 (phospho S339) antibody (ab74012)

Immunocytochemistry/ Immunofluorescence - CXCR4 (phospho S339) antibody (ab74012)

Immunofluorescence analysis of HeLa cells using ab74012, at 1/500 dilution, in the presence (right panel) or absence (left panel) of the immunising phosphopeptide.

References for Anti-CXCR4 (phospho S339) antibody (ab74012)

This product has been referenced in:

  • Nasser MWet al. Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB(2) in Modulating Breast Cancer Growth and Invasion. PLoS One 6:e23901 (2011). WB; Human.Read more (PubMed: 21915267) »

See 1 publication for this product

Publishing research using ab74012? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"